Your browser doesn't support javascript.
loading
Repeat expansions confer WRN dependence in microsatellite-unstable cancers.
van Wietmarschen, Niek; Sridharan, Sriram; Nathan, William J; Tubbs, Anthony; Chan, Edmond M; Callen, Elsa; Wu, Wei; Belinky, Frida; Tripathi, Veenu; Wong, Nancy; Foster, Kyla; Noorbakhsh, Javad; Garimella, Kiran; Cruz-Migoni, Abimael; Sommers, Joshua A; Huang, Yongqing; Borah, Ashir A; Smith, Jonathan T; Kalfon, Jeremie; Kesten, Nikolas; Fugger, Kasper; Walker, Robert L; Dolzhenko, Egor; Eberle, Michael A; Hayward, Bruce E; Usdin, Karen; Freudenreich, Catherine H; Brosh, Robert M; West, Stephen C; McHugh, Peter J; Meltzer, Paul S; Bass, Adam J; Nussenzweig, André.
Afiliação
  • van Wietmarschen N; Laboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Sridharan S; Laboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Nathan WJ; Laboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Tubbs A; Department of Oncology, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.
  • Chan EM; Laboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Callen E; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Wu W; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Belinky F; Laboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Tripathi V; Laboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Wong N; Laboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Foster K; Laboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Noorbakhsh J; Laboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Garimella K; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Cruz-Migoni A; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Sommers JA; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Huang Y; Department of Oncology, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.
  • Borah AA; Laboratory of Molecular Gerontology, National Institute on Aging, NIH, Baltimore, MD, USA.
  • Smith JT; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Kalfon J; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Kesten N; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Fugger K; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Walker RL; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Cambridge, MA, USA.
  • Dolzhenko E; DNA Recombination and Repair Laboratory, The Francis Crick Institute, London, UK.
  • Eberle MA; Genetics Branch, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Hayward BE; Illumina Inc., San Diego, CA, USA.
  • Usdin K; Illumina Inc., San Diego, CA, USA.
  • Freudenreich CH; Laboratory of Cell and Molecular Biology, National Institute of Diabetes, Digestive and Kidney Diseases, NIH, Bethesda, MD, USA.
  • Brosh RM; Laboratory of Cell and Molecular Biology, National Institute of Diabetes, Digestive and Kidney Diseases, NIH, Bethesda, MD, USA.
  • West SC; Department of Biology, Tufts University, Medford, MA, USA.
  • McHugh PJ; Laboratory of Molecular Gerontology, National Institute on Aging, NIH, Baltimore, MD, USA.
  • Meltzer PS; DNA Recombination and Repair Laboratory, The Francis Crick Institute, London, UK.
  • Bass AJ; Department of Oncology, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.
  • Nussenzweig A; Genetics Branch, National Cancer Institute, NIH, Bethesda, MD, USA.
Nature ; 586(7828): 292-298, 2020 10.
Article em En | MEDLINE | ID: mdl-32999459
ABSTRACT
The RecQ DNA helicase WRN is a synthetic lethal target for cancer cells with microsatellite instability (MSI), a form of genetic hypermutability that arises from impaired mismatch repair1-4. Depletion of WRN induces widespread DNA double-strand breaks in MSI cells, leading to cell cycle arrest and/or apoptosis. However, the mechanism by which WRN protects MSI-associated cancers from double-strand breaks remains unclear. Here we show that TA-dinucleotide repeats are highly unstable in MSI cells and undergo large-scale expansions, distinct from previously described insertion or deletion mutations of a few nucleotides5. Expanded TA repeats form non-B DNA secondary structures that stall replication forks, activate the ATR checkpoint kinase, and require unwinding by the WRN helicase. In the absence of WRN, the expanded TA-dinucleotide repeats are susceptible to cleavage by the MUS81 nuclease, leading to massive chromosome shattering. These findings identify a distinct biomarker that underlies the synthetic lethal dependence on WRN, and support the development of therapeutic agents that target WRN for MSI-associated cancers.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Repetições de Dinucleotídeos / Expansão das Repetições de DNA / Quebras de DNA de Cadeia Dupla / Helicase da Síndrome de Werner / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Nature Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Repetições de Dinucleotídeos / Expansão das Repetições de DNA / Quebras de DNA de Cadeia Dupla / Helicase da Síndrome de Werner / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Nature Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos